Zobrazeno 1 - 10
of 60
pro vyhledávání: ''
Publikováno v:
Breast Disease. 41:273-278
BACKGROUND: Mondor disease is superficial thrombophlebitis of the thoracoabdominal wall, mid-upper arm, and penis. Although it is usually a benign disease requiring no specific treatment, little is known about this disease owing to its rarity. OBJECT
Autor:
Sadaf, Jafferbhoy, Manoj, Gowda S, Kirti Katherine, Kabeer, Zatinahhayu, Mohd-Isa, Seema, Salehi-Bird, Sekhar, Marla, Sankaran, Narayanan, Soni, Soumian
Publikováno v:
Breast Disease. 41:165-173
BACKGROUND AND OBJECTIVES: MRI is generally performed to assess response to Neo-adjuvant systemic therapy (NAST) in breast cancer. OBJECTIVE: To assess role of MRI in determining the probability of having residual disease in patients undergoing NAST.
Publikováno v:
Cancer Biomarkers. 32:559-567
BACKGROUND: CA125 level normalization at different chemotherapy cycles has been reported to be a prognosticator in advanced epithelial ovarian cancer. OBJECTIVE: In the present study, we investigated whether the time (in days) to CA125 normalization
Publikováno v:
Breast Disease. 41:89-95
INTRODUCTION: The management of complex cysts of the breast is an ongoing topic of discussion. The aim of this study was to determine the prevalence of underlying malignancy in radiologically diagnosed complex cysts, and to assess whether watchful wa
Autor:
Linu Abraham Jacob, M C Suresh Babu, Smitha Saldanha, L K Rajeev, A H Rudresha, K N Lokesh, Usha Amirtham, A. Thottian, D. Lokanatha, Shina Goyal
Publikováno v:
Breast Disease. 41:115-121
BACKGROUND: The present era of individualized treatment for breast cancer is influenced by the initial disease status including the anatomical extent, grade, and receptor status. An accurate preoperative staging is the basis of treatment planning and
Autor:
Yukiko Miyamura, Shunji Kamigaki, Jun Yamamura, Yukihiko Hahimot, Hironobu Manabe, Yoshifumi Komoike, Toshikazu Ito, Junya Fujita, Yumiko Tanaka, Hiroki Osato, Wataru Shinzaki
Publikováno v:
Breast Disease. 41:109-114
BACKGROUND: Current guidelines define primary and secondary endocrine resistance according to the periods of adjuvant endocrine therapy (adj-ET); however, the relationship between adj-ET period and endocrine resistance remains unclear. OBJECTIVE: We
Autor:
Adel El-Badrawy
Publikováno v:
Breast Disease. 40:275-281
BACKGROUND: Multiple primary malignancies are two or more malignancies in an individual without any relationship between the tumors. The development of improved diagnostic techniques, increased survival of cancer patients and the growing life expecta
Autor:
Giovanni Pierorazio, Francesco Pavese, Giampiero Porzio, Katia Cannita, V. Cocciolone, Lucilla Verna, Silvia Rotondaro, Corrado Ficorella, Tina Sidoni, Alessandro Parisi
Publikováno v:
Breast Disease. 40:257-262
BACKGROUND: Despite the increase in chances of cure for early breast cancer (EBC) patients, approximately 20–45% of them will experience a disease recurrence, particularly bone metastases in 60–80% of cases, which occur more frequently in luminal
Autor:
Atanas Ignatov, Piotr Czapiewski, Thomas Kalinski, Willi Pieper, Norbert Nass, Johannes Haybaeck
Publikováno v:
Cancer Biomarkers. 32:161-173
BACKGROUND: Neuronatin (NNAT) determined by immunohistochemistry is a negative prognostic biomarker for breast cancer, independent of the major clinicopathological markers. OBJECTIVE: Here, we investigated whether NNAT is also a predictive biomarker
Publikováno v:
Breast Disease. 40:177-182
BACKGROUND: Of the most common imaging modalities for breast cancer diagnosis – mammogram (MAM), ultrasound (US), magnetic resonance imaging (MRI) – it has not been well established which of these most accurately corresponds to the histological t